- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT04984005
Metabolisen oireyhtymän ja siihen liittyvien aineenvaihduntasairauksien erilaisten harjoitusmallien vuorovaikutus- ja säätelymekanismi
In order to obtain suitable exercise intervention model for children and adolescents with obese or metabolic syndrome in China, we conduct a RCT to examine the effects of different intensity exercise intervention on weight, and other cardiometabolic risk factors among children and adolescents, we also test the effects of exercise interventions on multi-omics such as metabolomics, gut microbiome, genetics, and explore the potential mechanisms by which exercise interventions modulate cardiometabolic risk. This is a randomized controlled study. Children and adolescents with obesity or metabolic syndrome were randomly divided into three groups, including low intensity exercise training group, moderate and intermittent high intensity exercise training group. The investigators will obtain organ hydrodynamics indexes by abdominal ultrasound and computational fluid dynamics technology, and obtain the metabolic regulation mechanism of the body in response to exercise through the detection of metabolism related small molecules in blood and urine and the analysis of intestinal flora, so as to explore the potential value and mechanism of different exercise modes in the treatment of obesity and metabolic syndrome. At the same time, the behavior and self-consciousness of children and adolescents will be investigated to obtain the suitable exercise intervention model for Chinese children and adolescents with obesity and metabolic syndrome. In conclusion, this study aims to demonstrate which exercise mode can alleviate obesity or reverse metabolic diseases, analyze which factors can sense exercise, and explore the potential mechanisms through mutil-omic approach, so as to improve metabolic syndrome.
Tutkimuksen yleiskatsaus
Tila
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Kiina
- Peking University Third Hospital
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Clinical diagnosis of overweight or obesity or metabolic syndrome;
- Good academic performance in school;
- Willing to sign informed consent.
Exclusion Criteria:
- Clinical diagnosis of Cushing syndrome;
- Pathological obesity such as Prader-Willi syndrome and obesity caused by drug factors;
- Participated in other intervention studies within the previous three months;
- participant or their guardian has obvious intellectual or mental abnormalities.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Ennaltaehkäisy
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Matalan intensiteetin harjoitteluryhmä
|
The exercise method is broadcast gymnastics and sports dance. Through the design of different exercise intensities, This arm receives a low-intensity exercise training. |
|
Kokeellinen: Kohtalaisen intensiteetin harjoitusryhmä
|
The exercise method is broadcast gymnastics and sports dance. Through the design of different exercise intensities, This arm receives a moderate-intensity exercise training. |
|
Kokeellinen: Jaksottainen korkean intensiteetin harjoitteluryhmä
|
The exercise method is broadcast gymnastics and sports dance. Through the design of different exercise intensities, This arm receives a high-intensity exercise training. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Changes from Baseline BMI z-score after 3 months of exercise
Aikaikkuna: Before and after three months (12 weeks) of exercise training
|
BMI-for-age z-score calculated using the WHO 2007 growth reference for children and adolescents aged 5-19 years. BMI z-score is the primary outcome specified in the statistical analysis plan for the 12-week intervention report; the other registered outcomes are secondary or are reported separately. |
Before and after three months (12 weeks) of exercise training
|
|
Changes from Baseline Obesity Indicators after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
BMI in kg/m^2 |
Before and after three months of exercise training
|
|
Changes from Baseline Body Fat Composition after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Body fat composition (%) |
Before and after three months of exercise training
|
|
Changes from Baseline Peak Metabolic Equivalent after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Peak Metabolic Equivalent in MET |
Before and after three months of exercise training
|
|
Changes from Baseline Blood Pressure after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Blood pressure in mmHg |
Before and after three months of exercise training
|
|
Changes from Baseline Fasting Blood Glucose after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Fasting Blood Glucose in mmol/L |
Before and after three months of exercise training
|
|
Changes from Baseline Total Serum Cholesterol after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Total Serum Cholesterol in mmol/L |
Before and after three months of exercise training
|
|
Changes from Baseline Triglyceride after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Triglyceride in mmol/L |
Before and after three months of exercise training
|
|
Changes from Baseline Serum High-density Lipoprotein Cholesterol after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Serum High-density Lipoprotein Cholesterol in mmol/L |
Before and after three months of exercise training
|
|
Changes from Baseline Serum Low-density Lipoprotein Cholesterol after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Serum Low-density Lipoprotein Cholesterol in mmol/L |
Before and after three months of exercise training
|
|
Changes from Baseline Sexual Hormones after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Detection of hormone indicators related to growth and development |
Before and after three months of exercise training
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Changes from Baseline Exercise Performance after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
VO2max/Kg in mL/min/Kg |
Before and after three months of exercise training
|
|
Changes from Baseline Hepatic Hemodynamic Index after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
wall shear stress in proper hepatic artery,Pa |
Before and after three months of exercise training
|
|
Changes from Baseline Bone Mineral Density after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Using ultrasound bone density instruments for detection |
Before and after three months of exercise training
|
|
Changes from Baseline C-reactive protein after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Inflammatory Biomarker C-reactive protein in mg/L |
Before and after three months of exercise training
|
|
Changes from Baseline Oxidative Stress Biomarkers after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Oxidative Stress Biomarker MDA in nmol/mL |
Before and after three months of exercise training
|
|
Changes from Baseline Serum Metabolomics after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Metabolomics |
Before and after three months of exercise training
|
|
Changes from Baseline Oral and Gut Microbiome after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
oral and gut microbiome |
Before and after three months of exercise training
|
|
Changes from Baseline Viromics after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
viromics |
Before and after three months of exercise training
|
|
Exome sequencing and genome sequencing
Aikaikkuna: At baseline
|
genetics |
At baseline
|
|
Changes from Baseline Proteomics after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
proteomics |
Before and after three months of exercise training
|
|
Changes from Baseline Volatile Organic Compounds in Breath after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Collect exhaled gas and use mass spectrometry for small molecule detection |
Before and after three months of exercise training
|
|
Changes from Baseline Attention performance after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Attention Survey Questionnaire |
Before and after three months of exercise training
|
|
Changes from Baseline Sleep Quality after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Wearing a heart rate monitoring watch to collect data |
Before and after three months of exercise training
|
|
Changes from Baseline Total Thyroid Hormone after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Total Thyroid Hormone in nmol/L |
Before and after three months of exercise training
|
|
Changes from Baseline Liver steatosis after 3 months of exercise
Aikaikkuna: Before and after three months of exercise training
|
Abdominal ultrasound evaluation of the presence of hepatic steatosis |
Before and after three months of exercise training
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
- Ravitsemushäiriöt
- Metaboliset sairaudet
- Yliravitsemus
- Kehon paino
- Glukoosiaineenvaihduntahäiriöt
- Insuliiniresistenssi
- Hyperinsulinismi
- Patologiset tilat, merkit ja oireet
- Käyttäytyminen
- Ravitsemukselliset ja aineenvaihduntataudit
- Merkit ja oireet
- Ylipainoinen
- Lihavuus
- Metabolinen oireyhtymä
- Motorinen toiminta
Muut tutkimustunnusnumerot
- M2021263
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .